NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02261805 2018-04-23A Phase I/II Study of Ganetespib in Combination With DoxorubicinGeorgetown UniversityPhase 1/2 Terminated11 enrolled 7 charts